 |
|
|
|
July 2000 Cover
|
|
A report in an April issue of the journal
AIDS states that treating AIDS patients with powerful immune activation therapy could have dangerous results. Researchers used a mathematical model to analyze the treatment
using data from three patients who were on a five-drug regimen. The activation of many of the patient's T-cells could deplete HIV-infected and healthy T-cell populations. Researchers warn that if the virus reproduces
quickly enough it can overtake the drugs' benefits.
Editor's Note: from AIDS
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
